Obsessive-Compulsive Disorder (OCD) in teenagers, marked by intrusive thoughts and repetitive behaviors, impacts social life, academics, and well-being. Early diagnosis and treatment are critical, as delays worsen long-term outcomes. Selective Serotonin Reuptake Inhibitors (SSRIs), like escitalopram, are the main medications, boosting serotonin to ease symptoms. However, 40%-60% of teens see insufficient relief, though severe side effects are rare, requiring individualized assessment.
Cognitive Behavioral Therapy (CBT) is the first-line treatment for mild to moderate OCD. A 2022 meta-analysis found combining CBT with SSRIs outperforms medication alone, especially when CBT follows or joins medication. For non-responders to SSRIs or CBT, atypical antipsychotics may be considered, though other drugs show limited efficacy compared to SSRIs or CBT. Tailored treatment is essential.
Finding the right approach involves ongoing monitoring, as responses vary. Healthcare providers must adjust medications or explore alternatives with families, ensuring regular follow-ups and open dialogue. Combining SSRIs, CBT, and early intervention helps teens manage OCD effectively, supporting a balanced life.
